Skip to main content
Revive Therapeutics Ltd. (FRA:31R)
Germany flag Germany · Delayed Price · Currency is EUR
0.0050
0.00 (0.00%)
Last updated: Dec 5, 2025, 3:51 PM CET

Revive Therapeutics Cash Flow Statement

Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year
 TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Sep '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Net Income
-10.82-11.01-5.62-6.32-17.81-20.12
Upgrade
Depreciation & Amortization
000000
Upgrade
Asset Writedown & Restructuring Costs
9.389.382.340.78--
Upgrade
Loss (Gain) From Sale of Investments
00.010.050.09--0.18
Upgrade
Stock-Based Compensation
0.410.320.14-1.048.57
Upgrade
Other Operating Activities
-0.07-0.07-0.010.180.172.72
Upgrade
Change in Accounts Payable
0.470.290.04-0.763.580.21
Upgrade
Change in Other Net Operating Assets
0.190.31-0.230.01-0.030.5
Upgrade
Operating Cash Flow
-0.44-0.77-3.29-6.03-13.06-8.31
Upgrade
Sale (Purchase) of Intangibles
------3
Upgrade
Investment in Securities
--0.03---0.28
Upgrade
Investing Cash Flow
--0.03----2.72
Upgrade
Long-Term Debt Issued
-0.07---0.02
Upgrade
Total Debt Issued
0.070.07---0.02
Upgrade
Long-Term Debt Repaid
--0.03-0.19-0.15-0.15-0.15
Upgrade
Net Debt Issued (Repaid)
0.070.04-0.19-0.15-0.15-0.13
Upgrade
Issuance of Common Stock
0.15-2.14.590.3828.67
Upgrade
Other Financing Activities
-0.03-0.07-0.240.15-2.3
Upgrade
Financing Cash Flow
0.190.041.984.20.3826.24
Upgrade
Net Cash Flow
-0.25-0.76-1.31-1.83-12.6815.22
Upgrade
Free Cash Flow
-0.44-0.77-3.29-6.03-13.06-8.31
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.01-0.02-0.04-0.03
Upgrade
Levered Free Cash Flow
0.14-0.18-2.04-4.25-6.66-5.4
Upgrade
Unlevered Free Cash Flow
0.14-0.18-2.02-4.23-6.62-5.35
Upgrade
Change in Working Capital
0.660.6-0.19-0.753.540.71
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.